Mexico pays nearly $160 mn for COVAX vaccine plan
The latest payment will allow Mexico to acquire enough doses of a vaccine to immunise up to a fifth of the country’s population of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA issues warning letter to Shilpa Medicare for Jadcherla facility, Telangana
The company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from…
Mental health drugs market: Assessing the growth potential
Philippa Salter, Healthcare Analyst, GlobalData points out that any novel therapies and drugs that can tackle treatment-resistant…
Bharat Biotech told to provide phase II data of Covaxin before phase III trial
The SEC also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so…
US, AstraZeneca sign pact for COVID-19 antibody treatment used to treat Trump
The agreement, under Operation Warp Speed, is to develop a monoclonal antibody cocktail that can prevent COVID-19, especially in…
Deal value in the M&A market decreased in Sept 2020 compared to $35.7 bn in Aug 2020
In September 2020, the healthcare industry reported 84 deals worth $28.2 billion as compared to the last 12-month average…
Mental Health: A challenge and an opportunity
On Mental Health Day, Jayasree K Iyer, Executive Director, Access to Medicine Foundation highlights that mental health should be…
More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand…
Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories
Navigating a COVIDitised world
The pandemic has spurred governments to invest in healthcare systems and convinced companies that R&D budgets cannot be cut.…
Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study
The FAITH study enrolled a total of 158 hospitalised patients with moderate COVID-19 in India